LEADER 01437nam0 22003251i 450 001 UON00082623 005 20231205102434.285 010 $a08-569-8113-3 100 $a20020107d1990 |0itac50 ba 101 $aeng 102 $aGB 105 $a|||| ||||| 200 1 $aSaqqara tombs II. The mastabas of Meru, Semdenti, Khui and others$fA.B. Lloyd A.J. Spencer, A. El-Khouli 210 $aLondon$cEgypt Exploration Society$d1990 215 $axv, 53 p., [36] p. di tav.$d32 cm 410 1$1001UON00066692$12001 $aArchaeological Survey of Egypt$fEdited by F. L. Griffith$v40 606 $aTOMBE EGIZIANE PRIVATE$xSaqqara$xAntico Regno$3UONC021439$2FI 606 $aSCAVI ARCHEOLOGICI$xNecropoli private$3UONC025119$2FI 620 $aGB$dLondon$3UONL003044 700 1$aLLOYD$bAlan B.$3UONV051920$0183457 701 1$aKHOULI$bAli : el$3UONV052834$0661385 701 1$aSPENCER$bA. J.$3UONV042929$0107796 712 $aEgypt Exploration Society$3UONV251076$4650 790 1$aSPENCER, Jeffrey$ySPENCER, A. J.$3UONV042928 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00082623 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI EG II e 001/40 $eSI AA 22900 5 001/40 996 $aSaqqara tombs II. The mastabas of Meru, Semdenti, Khui and others$91297149 997 $aUNIOR LEADER 02297nam 2200385 450 001 9910830930803321 005 20231006191628.0 010 $a3-527-61161-4 035 $a(CKB)4100000000641156 035 $a(NjHacI)994100000000641156 035 $a(EXLCZ)994100000000641156 100 $a20231006d2008 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHandbook of Tuberculosis /$fStefan H. E. Kaufmann [and three others] 210 1$a[Place of publication not identified] :$cJohn Wiley & Sons, Inc.,$d2008. 215 $a1 online resource (339 pages) 311 $a3-527-31683-3 327 $aV. 1. Molecular biology and biochemistry / edited by Stefan H.E. Kaufmann and Eric Rubin -- v. 2. Immunology and cell biology / edited by Stefan H.E. Kaufmann and Warwick J. Britton -- v. 3. Clinics, diagnostics, therapy, and epidemiology / edited by Stefan H.E. Kaufmann and Paul van Helden --. 330 $aCoinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific of all researchers in the field. Divided into three clearly structured volumes, the first deals with molecular biology and biochemistry of the pathogen, including genetics and genomics, as well as drug design. The second volume covers cell biology, immunology and vaccine development, while the third is devoted to epidemiology and clinical approaches, including drug resistance, veterinary aspects and clinical field trials. With one new infection worldwide every second, this is an essential reference for bacteriologists, immunologists, pathologists and pathophysiologists, molecular and cell biologists, as well as those working in the pharmaceutical industry. 606 $aMycobacterium tuberculosis 606 $aTuberculosis 615 0$aMycobacterium tuberculosis. 615 0$aTuberculosis. 676 $a616.2 700 $aKaufmann$b Stefan H. E.$042605 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910830930803321 996 $aHandbook of Tuberculosis$93982493 997 $aUNINA